Multifunctional Platform Technology for Magnetically Actuated Controlled Drug Release from Biodegradable Scaffolds
MAD Control aims to develop a multifunctional platform for biodegradable cardiovascular scaffolds that enables precise, on-demand drug release through real-time imaging and magnetic actuation.
Projectdetails
Introduction
The extremely popular engineering field of drug-eluting biodegradable scaffolds for regenerative medicine, cancer treatment, and cardiovascular therapies has largely failed to ensure therapy at the right place, at the right time, and with the right dose. Control of actuated drug release is the grand challenge to solve.
Challenges in Current Technologies
Previous attempts struggled because, at this time, no technology is able to cope with the influence of scaffold alterations with degradation.
Project Overview
MAD Control will establish a multifunctional platform for biodegradable cardiovascular scaffolds with the following objectives:
- Make model-based predictions of degradation states from real-time imaging.
- Reveal which actuation is best for targeted drug release in the actual degradation state.
- Uncover how to generate this actuation.
Platform Components
The platform comprises magnetic nanoparticles in hybrid scaffold materials, tailored for a double function:
- Sensors for magnetic particle imaging.
- Actuators for drug release with magnetic fluid hyperthermia.
The imaging results are matched with degradation states based on prediction models to be created, and magnetic fluid hyperthermia is induced in a multimodal device to be developed.
Control Mechanism
Control is achieved by coupling material data streams, acquired through automated and comprehensive in-situ measurements of the hybrid materials’ properties, with modelling and control algorithms.
Expected Outcomes
Thus, the multifunctional platform promises a theranostic breakthrough: on-demand release of a precise amount of drugs that can be deliberately chosen. Targeting efficacy is finally measured in vivo, after extensive in-vitro testing.
Transformative Impact
The outcome of this project will be truly transformative, opening new possibilities for research and development of biodegradable implants as well as of magnetic transport and release systems for active agents. Importantly, it is not limited to cardiovascular applications.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 1.495.288 |
Totale projectbegroting | € 1.495.288 |
Tijdlijn
Startdatum | 1-1-2024 |
Einddatum | 31-12-2028 |
Subsidiejaar | 2024 |
Partners & Locaties
Projectpartners
- UNIVERSITAETSKLINIKUM AACHENpenvoerder
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Advanced 3D in vitro models based on magnetically-driven docking of modular microscaffoldsThis project aims to develop 3D modular co-culture systems using magnetic microscaffolds to replicate brain tumor microenvironments for drug screening and cancer therapy testing. | ERC Proof of... | € 150.000 | 2023 | Details |
Intelligent Device and Computational Software to Control Mechanical Stress and Deformation for Biological TestingISBIOMECH aims to develop a novel intelligent system for controlling mechanical environments in biological testing, enhancing in-vitro therapies and drug discovery for various pathologies. | ERC Proof of... | € 150.000 | 2023 | Details |
Bidirectional remote deep brain control with magnetic anisotropic nanomaterialsBRAINMASTER aims to develop a scalable, wireless neuromodulation system using magnetic nanodiscs for deep brain therapy and imaging, enhancing cognitive training and treatment for neurological disorders. | ERC Starting... | € 1.500.000 | 2024 | Details |
Biodegradable MEMS implants for nerve repairDevelop biodegradable MEMS implants for nerve repair using innovative mechanical stimulation strategies to enhance neural regeneration post-injury. | ERC Starting... | € 1.672.968 | 2023 | Details |
Bioorthogonal Iontronic Chemistry: Spatiotemporal Drug Release with Electronic PrecisionDevelop a programmable drug delivery system using Biontronic Chemistry for precise spatiotemporal release, enhancing treatment efficacy while minimizing side effects in various therapies. | ERC Starting... | € 1.496.795 | 2024 | Details |
Advanced 3D in vitro models based on magnetically-driven docking of modular microscaffolds
This project aims to develop 3D modular co-culture systems using magnetic microscaffolds to replicate brain tumor microenvironments for drug screening and cancer therapy testing.
Intelligent Device and Computational Software to Control Mechanical Stress and Deformation for Biological Testing
ISBIOMECH aims to develop a novel intelligent system for controlling mechanical environments in biological testing, enhancing in-vitro therapies and drug discovery for various pathologies.
Bidirectional remote deep brain control with magnetic anisotropic nanomaterials
BRAINMASTER aims to develop a scalable, wireless neuromodulation system using magnetic nanodiscs for deep brain therapy and imaging, enhancing cognitive training and treatment for neurological disorders.
Biodegradable MEMS implants for nerve repair
Develop biodegradable MEMS implants for nerve repair using innovative mechanical stimulation strategies to enhance neural regeneration post-injury.
Bioorthogonal Iontronic Chemistry: Spatiotemporal Drug Release with Electronic Precision
Develop a programmable drug delivery system using Biontronic Chemistry for precise spatiotemporal release, enhancing treatment efficacy while minimizing side effects in various therapies.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Smart 4D biodegradable metallic shape-shifting implants for dynamic tissue restorationBIOMET4D aims to revolutionize reconstructive surgery with shape-morphing implants for dynamic tissue restoration, enhancing regeneration while reducing costs and invasiveness. | EIC Pathfinder | € 4.039.541 | 2022 | Details |
On-Demand Bioresorbable OptoElectronic System for In-Vivo and In-Situ Monitoring of Chemotherapeutic DrugsDevelop a bioresorbable chemical sensing system for real-time monitoring of doxorubicin in-vivo, enhancing personalized cancer treatment while eliminating the need for device retrieval surgery. | EIC Pathfinder | € 2.606.250 | 2022 | Details |
Wireless deep BRAIN STimulation thrOugh engineeRed Multifunctinal nanomaterialsBRAINSTORM aims to develop a scalable wireless neuromodulation technology using smart magnetic nanomaterials to selectively control deep brain neurons for therapeutic applications in Fragile X syndrome. | EIC Pathfinder | € 3.083.850 | 2023 | Details |
A synaptic mechanogenetic technology to repair brain connectivityDeveloping a mechanogenetic technology using magnetic nanoparticles to non-invasively regulate neural circuits for treating treatment-resistant brain disorders like stroke and epilepsy. | EIC Pathfinder | € 3.543.967 | 2023 | Details |
MagnetoElectric and Ultrasonic Technology for Advanced BRAIN modulationMETA-BRAIN aims to develop non-invasive, precise control of brain activity using magnetoelectric nanoarchitectures and ultrasonic technologies, enhancing treatment for neurological disorders. | EIC Pathfinder | € 2.987.655 | 2024 | Details |
Smart 4D biodegradable metallic shape-shifting implants for dynamic tissue restoration
BIOMET4D aims to revolutionize reconstructive surgery with shape-morphing implants for dynamic tissue restoration, enhancing regeneration while reducing costs and invasiveness.
On-Demand Bioresorbable OptoElectronic System for In-Vivo and In-Situ Monitoring of Chemotherapeutic Drugs
Develop a bioresorbable chemical sensing system for real-time monitoring of doxorubicin in-vivo, enhancing personalized cancer treatment while eliminating the need for device retrieval surgery.
Wireless deep BRAIN STimulation thrOugh engineeRed Multifunctinal nanomaterials
BRAINSTORM aims to develop a scalable wireless neuromodulation technology using smart magnetic nanomaterials to selectively control deep brain neurons for therapeutic applications in Fragile X syndrome.
A synaptic mechanogenetic technology to repair brain connectivity
Developing a mechanogenetic technology using magnetic nanoparticles to non-invasively regulate neural circuits for treating treatment-resistant brain disorders like stroke and epilepsy.
MagnetoElectric and Ultrasonic Technology for Advanced BRAIN modulation
META-BRAIN aims to develop non-invasive, precise control of brain activity using magnetoelectric nanoarchitectures and ultrasonic technologies, enhancing treatment for neurological disorders.